"Ospedale di Rovigo"

During the past decade, Ospedale Santa Maria della Misericordia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Maria della Misericordia" #1 sponsor was "Gruppo di Ricerca GISSI" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari" with 1 trials sponsored and "Fadoi Foundation, Italy" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Maria della Misericordia" #1 collaborator was "Consorzio Mario Negri Sud" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Maria della Misericordia" are "Heart Failure" (6 trials), "Cardiovascular Disease" (2 trials), "Ventricular Tachycardia" (2 trials), "Atrial Fibrillation" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Ospedale Santa Maria della Misericordia" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Maria della Misericordia" are "Drug" (7 trials), "Device" (4 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "COVID-19" (1 trials), "CRT-D" (1 trials) and "Conventional hemodialysis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Maria della Misericordia" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Santa Maria della Misericordia". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ospedale Santa Maria della Misericordia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Maria della Misericordia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".